Press release from Companies: Curasight to present at HC Andersen Capital

Press release from Companies: Curasight to present at Redeye Fight Cancer Seminar

Reports: Interim Report January – September 2022

Press release from Companies: Curasight to present at HC Andersen Capital

Press release from Companies: Curasight to present at SEB Healthcare Seminar 2022

Press release from Companies: Curasight initiates pre-clinical studies with uTREAT[®] therapy in head and neck cancer (HNSCC) and neuroendocrine tumors (NET)

Press release from Companies: Transaction with shares in Curasight A/S made by managerial employee

Press release from Companies: Curasight to present at HC Andersen Capital

Reports: Interim Report January – June 2022

Press release from Companies: Recruitment completed in uPAR-PET study in brain cancer

Press release from Companies: Transaction with shares in Curasight A/S made by managerial employee

Press release from Companies: Curasight issues warrants for launch of long-term incentive program